Literature DB >> 21775074

Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users.

Christine C Cloak1, Daniel Alicata, Linda Chang, Brian Andrews-Shigaki, Thomas Ernst.   

Abstract

BACKGROUND: Methamphetamine can be neurotoxic to the adult brain; however, many individuals first use methamphetamine during adolescence, and the drug's impact on this period of brain development is unknown. Therefore, we evaluated young methamphetamine users for possible abnormalities in brain metabolite concentrations.
METHODS: Anterior cingulate cortex (ACC), frontal white matter (FWM), basal ganglia, and thalamus were studied with localized proton magnetic resonance spectroscopy in 54 periadolescent (ages 13-23 years) methamphetamine users and 53 comparison subjects. The concentrations of major brain metabolites and their associations with age, sex and cognition were assessed.
RESULTS: FWM total-creatine correlated with age in methamphetamine-using males and comparison females, but not comparison males or methamphetamine-using females, leading to a drug by sex by age interaction (p=0.003) and ACC choline-containing compounds (CHO) correlated with age only in comparison males leading to a drug by sex by age interaction (p=0.03). Higher ACC CHO was associated with faster performance on the Stroop Interference task in the control males. Male methamphetamine users had slowest performance on the Stroop Interference task and did not show age-appropriate levels of ACC CHO.
CONCLUSIONS: The altered age-appropriate levels of ACC CHO and poorer executive function in male methamphetamine users suggest methamphetamine abuse may interfere with brain maturation. These periadolescents did not have the abnormal neuronal markers previously reported in adult methamphetamine users, suggesting that neuronal abnormalities may be the result of long-term use or interference in normal cortical maturation, emphasizing the need for early intervention for young methamphetamine users.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775074      PMCID: PMC3214603          DOI: 10.1016/j.drugalcdep.2011.06.017

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  52 in total

1.  How can we learn about developmental processes from cross-sectional studies, or can we?

Authors:  H C Kraemer; J A Yesavage; J L Taylor; D Kupfer
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

2.  Sex differences in brain maturation during childhood and adolescence.

Authors:  M D De Bellis; M S Keshavan; S R Beers; J Hall; K Frustaci; A Masalehdan; J Noll; A M Boring
Journal:  Cereb Cortex       Date:  2001-06       Impact factor: 5.357

3.  Mapping cortical change across the human life span.

Authors:  Elizabeth R Sowell; Bradley S Peterson; Paul M Thompson; Suzanne E Welcome; Amy L Henkenius; Arthur W Toga
Journal:  Nat Neurosci       Date:  2003-03       Impact factor: 24.884

Review 4.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

5.  Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero.

Authors:  L M Smith; L Chang; M L Yonekura; C Grob; D Osborn; T Ernst
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

6.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; Y S Ding; M Sedler; J Logan; D Franceschi; J Gatley; R Hitzemann; A Gifford; C Wong; N Pappas
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

7.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

8.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

9.  Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.

Authors:  Lisa M McFadden; Amanda J Hoonakker; Paula L Vieira-Brock; Kristen A Stout; Nicole M Sawada; Jonathan D Ellis; Scott C Allen; Elliot T Walters; Shannon M Nielsen; James W Gibb; Mario E Alburges; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

Review 10.  Fast robust automated brain extraction.

Authors:  Stephen M Smith
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

View more
  9 in total

1.  Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users.

Authors:  Christine C Cloak; Daniel Alicata; Thomas M Ernst; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-15       Impact factor: 4.147

Review 2.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

Review 3.  Genetic influences on brain developmental trajectories on neuroimaging studies: from infancy to young adulthood.

Authors:  Vanessa Douet; Linda Chang; Christine Cloak; Thomas Ernst
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

4.  Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration.

Authors:  Atul P Daiwile; Patricia Sullivan; Subramaniam Jayanthi; David S Goldstein; Jean Lud Cadet
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

5.  Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Authors:  Young-Hoon Sung; Paul D Carey; Dan J Stein; Helen L Ferrett; Bruce S Spottiswoode; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Behav Brain Res       Date:  2013-03-04       Impact factor: 3.332

Review 6.  Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neurosci Biobehav Rev       Date:  2022-04-20       Impact factor: 9.052

7.  Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse.

Authors:  Joseph O'Neill; Marc C Tobias; Matthew Hudkins; Edythe D London
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

8.  N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users.

Authors:  Jinsong Tang; Joseph O'Neill; Jeffry R Alger; Zhiwei Shen; Maritza C Johnson; Edythe D London
Journal:  Int J Neuropsychopharmacol       Date:  2019-01-01       Impact factor: 5.176

9.  Metabolite Alternations in the Dopamine Circuit Associated with Methamphetamine-Related Psychotic Symptoms: A Proton Magnetic Resonance Spectroscopy Study.

Authors:  Javad Sheikhi Koohsar; Fariborz Faeghi; Raheleh Rafaiee; Mohammad Niroumand Sarvandani; Sadegh Masjoodi; Hamid Kalalian Moghaddam
Journal:  Iran J Psychiatry       Date:  2022-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.